Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

857 ARTÍCULOS , VIENDO DEL 631 AL 645

High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial

LoBue C, Chiang HS, Salter A, McClintock S, Nguyen TP, Logan R, Smernoff E, Pandya S, Hart J.

J Prev Alzheimers Dis. 2025 Feb;12(2):100023. doi: 10.1016/j.tjpad.2024.100023. Epub 2025 Jan 1.

Tablet-based Cognitive Assessment Tool (TabCAT) in a multisite study of early-onset Alzheimer's disease

Njamnshi WY, Chiotis K, Tsoy E, Blazhenets G, Maiti P, Zhang J, Allen IE, Rocha S, Shankar RP, Amuiri A, Lawson M, Aisen P, Beckett L, Eloyan A, Hammers DB, Kirby K, Koeppe R, Kukull WA, Toga AW, Atri A, Clark D, Day GS, Duara R, Graff-Radford NR, Grant I, Honig LS, Johnson ECB, Jones DT, Masdeu J, Mendez MF, Musiek E, Onyike CU, Riddle M, Rogalski E, Salloway S, Sha SJ, Turner RS, Wingo TS, Wolk DA, Womack K, Kramer JH, Touroutoglou A, Brickhouse MJ, Jack CR Jr, Vemuri P, Taurone A, Thangarajah M, Nudelman K, Carrillo MC, Dickerson BC, Apostolova LG, Possin KL, Rabinovici GD, La Joie R; LEADS Consortium.

Alzheimers Dement. 2025 Dec;21(12):e71012. doi: 10.1002/alz.71012.

Clinical Pathways for Diagnosing Neurocognitive Disorders: Insights From Process Mining a Memory Clinic Cohort

Singh Solorzano C, Orini S, Festari C, Buscarnera S, Rossato F, Pievani M, Cotta Ramusino M, Massa F, Gatta R, Frisoni GB.

J Am Med Dir Assoc. 2025 Oct;26(10):105774. doi: 10.1016/j.jamda.2025.105774. Epub 2025 Aug 5.

Cognitive care at your fingertips: A systematic review of telemedicine potential and barriers in rehabilitation for dementia

Calderone A, Marra A, Latella D, De Pasquale P, Pignolo L, Maggio MG, Calabrò RS.

J Alzheimers Dis. 2025 Oct;107(3):910-959. doi: 10.1177/13872877251365565. Epub 2025 Aug 6.

Transcranial Alternating Current Stimulation and Cognitive Training Enhanced Performance and Theta Activity in Adults With Cognitive Impairment

Cid-Fernández S, Nieto-Vieites A, Pereiro AX, Díaz F.

Psicothema. 2025 May;37(2):1-11. doi: 10.70478/psicothema.2025.37.11.

Comparisons of four cognitive-frailty measures in predicting dementia and disability

Chung JY, Hwang HF, Suprawesta L, Lin MR.

BMC Geriatr. 2025 Apr 10;25(1):245. doi: 10.1186/s12877-025-05874-0.

Independent validation and outlier analysis of EuroPOND alzheimer's disease staging model using ADNI and real-world clinical data

Wittens MMJ, Sima DM, Brys A, Struyfs H, Niemantsverdriet E, De Roeck E, Bastin C, Benoit F, Bergmans B, Bier JC, de Deyn PP, Deryck O, Hanseeuw B, Ivanoiu A, Picard G, Salmon E, Segers K, Sieben A, Thiery E, Tournoy J, van Binst AM, Versijpt J, Smeets D, Bjerke M, Bellio M, Oxtoby NP, Alexander DC, Ribbens A, Engelborghs S.

Alzheimers Res Ther. 2025 Jun 16;17(1):134. doi: 10.1186/s13195-025-01788-6.

Efficacy of Communication Bridge-2 for primary progressive aphasia: A randomized controlled trial of communication intervention

Rogalski E, Bona M, Esparza M, Fegter O, Schafer R, Mooney A, Fried-Oken M, Rademaker A, Roberts A.

Alzheimers Dement. 2025 Mar;21(3):e70088. doi: 10.1002/alz.70088.

A meta-analysis and systematic review of interventions to prevent or treat cognitive decline related to Alzheimer's disease in adults with Down syndrome

Munn EE, Montelongo A, Patel VK, Fodstad JC, Ciccarelli MR, Ptomey LT, Pangelinan MM.

Alzheimers Dement. 2025 Jul;21(7):e70471. doi: 10.1002/alz.70471.

Early detection and management of hearing loss to reduce dementia risk in older adults with mild cognitive impairment: findings from the treating auditory impairment and cognition trial (TACT)

Yu RC, Pavlou M, Schilder AGM, Bamiou DE, Lewis G, Lin FR, Livingston G, Proctor D, Omar R, Costafreda SG.

Age Ageing. 2025 Jan 6;54(1):afaf004. doi: 10.1093/ageing/afaf004.

The effect of tablet-based multimodal training on cognitive functioning in Alzheimer's disease: A randomized controlled trial

Zuschnegg J, Ropele S, Opriessnig P, Schmidt R, Russegger S, Fellner M, Leitner M, Spat S, Garcia ML, Strobl B, Ploder K, Pszeida M, Hofmarcher-Holzhacker MM, Stoegerer-Oberschmid E, Guttmann-Lattmanig A, Paletta L, Schüssler S, Koini M.

PLoS One. 2025 Aug 13;20(8):e0329931. doi: 10.1371/journal.pone.0329931. eCollection 2025.

Effect of Initiation and Continuous Adherence to ARBs Versus ACEIs on Risk of Adjudicated Mild Cognitive Impairment or Dementia

Derington CG, Berchie RO, Scharfstein DO, Andrews RM, Greene TH, Xu Y, King JB, Supiano MA, Sonnen JA, Williamson J, Pajewski NM, Pruzin JJ, Cohen JB, Bress AP.

J Gerontol A Biol Sci Med Sci. 2025 Jun 10;80(7):glaf028. doi: 10.1093/gerona/glaf028.

Protocol for a Randomized Phase II/III Double-Blind Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Extended-Release Metformin in Amnestic Mild Cognitive Impairment: Metformin in Alzheimer Dementia Prevention (MAP)

Luchsinger JA, Devanand D, Goldberg TE, Cammack S, Hernández-Santiago G, Oishi K, Jagust W, Baker S, Landau S, Yenokyan G, Betz J, Mayers S, Eyzaguirre LM, Hanley D; MAP Study Group.

Alzheimer Dis Assoc Disord. 2025 Apr-Jun 01;39(2):123-133. doi: 10.1097/WAD.0000000000000677. Epub 2025 May 28.

Association between social networking and dementia: A systematic review of observational studies

Arshad F, Boopalan D, Arora S, Rosen HJ, Alladi S.

Neuroscience. 2025 Jun 7;576:138-148. doi: 10.1016/j.neuroscience.2025.04.019. Epub 2025 Apr 19.

Sativex (nabiximols) for the treatment of Agitation & Aggression in Alzheimer's dementia in UK nursing homes: a randomised, double-blind, placebo-controlled feasibility trial

Albertyn CP, Guu TW, Chu P, Creese B, Young A, Velayudhan L, Bhattacharyya S, Jafari H, Kaur S, Kandangwa P, Carter B, Aarsland D.

Age Ageing. 2025 May 31;54(6):afaf149. doi: 10.1093/ageing/afaf149.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias